Published in Br J Audiol on December 01, 1999
Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum (1997) 5.57
Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. Arthritis Rheum (1991) 2.91
Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol (2001) 2.85
Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Review of the general methodology. Clin Exp Rheumatol (2001) 2.55
Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest (1997) 2.11
Genomic structure and identification of novel mutations in usherin, the gene responsible for Usher syndrome type IIa. Am J Hum Genet (2000) 1.76
Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome. Arthritis Rheum (2008) 1.69
Localization of Usher syndrome type II to chromosome 1q. Genomics (1990) 1.67
Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study. Rheumatology (Oxford) (2006) 1.55
Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest (1994) 1.53
Rapid methods to extract DNA and RNA from Cryptococcus neoformans. FEMS Yeast Res (2001) 1.52
Methotrexate in juvenile idiopathic arthritis: answers and questions. J Rheumatol (2000) 1.51
Antiphospholipid antibodies in paediatrics. Eur J Pediatr (1994) 1.46
Factor V Leiden mutation in a case with ischemic stroke: which relationship? A case report. Angiology (1998) 1.45
Three newly delimited species of Saccharomyces sensu stricto. Antonie Van Leeuwenhoek (1987) 1.43
Self-reported benefits of hearing aids by the hearing impaired. Br J Audiol (1988) 1.40
Vertebral and carotid artery dissection following chiropractic cervical manipulation. Neurosurg Rev (1999) 1.38
Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nat Med (1995) 1.36
Early predictors of outcome in juvenile idiopathic arthritis. Clin Exp Rheumatol (2004) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Hearing-aid selection: an integrated approach. Br J Audiol (1984) 1.32
Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. II. Early predictors of outcome. J Rheumatol (1997) 1.32
Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry. Ann Rheum Dis (2004) 1.30
[Leishmania tropica in Morocco. III--The vector of Phlebotomus sergenti. Apropos of 89 isolates]. Ann Parasitol Hum Comp (1991) 1.27
Leishmania-human immunodeficiency virus coinfection in the Mediterranean basin: isoenzymatic characterization of 100 isolates of the Leishmania infantum complex. J Infect Dis (1995) 1.25
Diabetes, cardiovascular risk factors and idiopathic sudden sensorineural hearing loss: a case-control study. Audiol Neurootol (2009) 1.24
Immune-mediated inner ear disease. Acta Otolaryngol (2006) 1.23
Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr (1996) 1.23
Facts, myths and legends on the prime industrial microorganism. J Ind Microbiol (1995) 1.22
Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. I. Outcome status. J Rheumatol (1997) 1.21
A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children. Arthritis Rheum (2008) 1.20
The enantiomers of phenprocoumon: pharmacodynamic and pharmacokinetic studies. Clin Pharmacol Ther (1976) 1.17
Serum interleukin-6 levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis. Clin Exp Rheumatol (1993) 1.16
Systematic review of the literature on the clinical effectiveness of the cochlear implant procedure in paediatric patients. Acta Otorhinolaryngol Ital (2011) 1.16
[Leishmania tropica in Morocco. IV--Intrafocal enzyme diversity]. Ann Parasitol Hum Comp (1991) 1.14
Gene mapping of Usher syndrome type IIa: localization of the gene to a 2.1-cM segment on chromosome 1q41. Am J Hum Genet (1995) 1.14
Auditory and academic performance of children with unilateral hearing loss. Scand Audiol Suppl (1988) 1.13
Performance of the preliminary definition of improvement in juvenile chronic arthritis patients treated with methotrexate. Italian Pediatric Rheumatology Study Group. Ann Rheum Dis (1998) 1.12
Radiologic progression in patients with juvenile chronic arthritis treated with methotrexate. J Pediatr (1998) 1.12
Osteoblastoma-like osteosarcoma. The Rizzoli Institute experience. Mod Pathol (1993) 1.12
Effect of caroxazone, a new antidepressant drug, on monoamine oxidases in healthy volunteers. Br J Clin Pharmacol (1981) 1.11
Some tuning fork tests revisited. Clin Otolaryngol Allied Sci (1979) 1.11
The endoplasmic reticulum-sarcoplasmic reticulum connection: distribution of endoplasmic reticulum markers in the sarcoplasmic reticulum of skeletal muscle fibers. Proc Natl Acad Sci U S A (1992) 1.10
Elevated circulating interleukin-7 levels in patients with systemic juvenile rheumatoid arthritis. J Rheumatol (1995) 1.10
Correlation between conventional disease activity measures in juvenile chronic arthritis. Ann Rheum Dis (1997) 1.10
Psychological profile and social behaviour of working adults with mild or moderate hearing loss. Acta Otorhinolaryngol Ital (2008) 1.09
PRINTO/PRES international website for families of children with rheumatic diseases: www.pediatric-rheumatology.printo.it. Ann Rheum Dis (2005) 1.09
Unilateral microfibrillar abnormalities in a case of asymmetric Marfan syndrome. Am J Hum Genet (1990) 1.08
Pharmacokinetic studies of 4'-epi-doxorubicin in cancer patients with normal and impaired renal function and with hepatic metastases. Cancer Treat Rep (1982) 1.08
Electrophoretic karyotyping as a taxonomic tool in the genus Saccharomyces. Antonie Van Leeuwenhoek (1993) 1.08
Clinical presentation and pathogenesis of cold-induced autoinflammatory disease in a family with recurrence of an NLRP12 mutation. Arthritis Rheum (2011) 1.06
Aural rehabilitation of hearing-impaired adults (official policy of the British Society of Audiology). Br J Audiol (1979) 1.06
Preliminary phase I study of 4'-epi-adriamycin. Cancer Treat Rep (1979) 1.06
Autoantibodies in juvenile dermatomyositis. Clin Exp Rheumatol (1990) 1.06
Quantitative GLC determination of cyclophosphamide and isophosphamide in biological specimens. J Pharm Sci (1974) 1.05
Tinnitus and suicide. Clin Otolaryngol Allied Sci (1994) 1.05
Lymphoid neogenesis in juvenile idiopathic arthritis correlates with ANA positivity and plasma cells infiltration. Rheumatology (Oxford) (2006) 1.05
Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis. Clin Exp Rheumatol (1999) 1.04
Factors influencing binaural hearing aid use. Br J Audiol (1986) 1.04
Prevalence of anticardiolipin antibodies in juvenile chronic arthritis. Ann Rheum Dis (1991) 1.03
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. Ann Rheum Dis (2001) 1.02
Clinical and genetic characterization of Italian patients affected by CINCA syndrome. Rheumatology (Oxford) (2006) 1.01
Extracellular enzymatic activity profiles in yeast and yeast-like strains isolated from tropical environments. J Appl Microbiol (2002) 1.01
Long-term clinical profile of children with the low-penetrance R92Q mutation of the TNFRSF1A gene. Arthritis Rheum (2011) 1.00
Anticardiolipin syndrome in childhood: a report of two cases. Clin Exp Rheumatol (1990) 0.99
Myophosphorylase deficiency affects muscle mitochondrial respiration as shown by 31P-MR spectroscopy in a case with associated multifocal encephalopathy. J Neurol Sci (1995) 0.98
Studies on the disposition of cyclophosphamide (NSC-26271) in tumor-bearing mice by means of gas chromatography-chemical ionization-mass fragmentography. Cancer Treat Rep (1976) 0.98
Noise-induced hearing loss: a study on the pharmacological protection in the Sprague Dawley rat with N-acetyl-cysteine. Acta Otorhinolaryngol Ital (2006) 0.98
Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis. Endocrinology (2001) 0.98
Circulating levels of interleukin 1 beta and of interleukin 1 receptor antagonist in systemic juvenile chronic arthritis. Clin Exp Rheumatol (1996) 0.98
The Crown-Crisp Experiential Index in patients complaining of tinnitus. Br J Audiol (1985) 0.97
Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication? Lupus (2007) 0.96
Abnormal regulation of interleukin 6 in systemic juvenile idiopathic arthritis. J Rheumatol (2001) 0.96
Factors affecting the efficacy of intraarticular corticosteroid injection of knees in juvenile idiopathic arthritis. J Rheumatol (2001) 0.96
Clinical investigation of hearing loss in the elderly. Clin Otolaryngol Allied Sci (1991) 0.96
Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum (2000) 0.96
Lateral approaches to the skull base. Acta Otorhinolaryngol Ital (2012) 0.95
Cavernous hemangioma of the external ear: case report and literature review. B-ENT (2010) 0.95
Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes. J Rheumatol (1999) 0.95
Analysis of the impact of professional involvement in evidence generation for the HTA Process, subproject "cochlear implants": methodology, results and recommendations. Acta Otorhinolaryngol Ital (2011) 0.95
Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease? J Rheumatol (1998) 0.94
Who prompts patients to consult about hearing loss? Br J Audiol (1996) 0.94
Asymmetric Marfan syndrome. Am J Med Genet (1988) 0.94
Efficacy of homeopathic treatment of skin reactions during radiotherapy for breast cancer: a randomised, double-blind clinical trial. Br Homeopath J (2000) 0.94
Mitochondrial electron transport and glycolysis are coupled in articular cartilage. Osteoarthritis Cartilage (2012) 0.94
Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis. Ann Rheum Dis (2007) 0.94
Yeast flora of grape berries during ripening. Microb Ecol (1982) 0.93
Role of interleukin-6 in growth failure: an animal model. Horm Res (2002) 0.93
Discordance between physician's and parent's global assessments in juvenile idiopathic arthritis. Rheumatology (Oxford) (2006) 0.93
Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis. J Rheumatol (1997) 0.93
Enhanced interleukin 1 and depressed interleukin 2 production in juvenile arthritis. J Rheumatol (1986) 0.93
Discordance between proxy-reported and observed assessment of functional ability of children with juvenile idiopathic arthritis. Rheumatology (Oxford) (2001) 0.93
The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis. Ann Rheum Dis (2007) 0.92
Heart levels of adriamycin in normal and tumor-bearing mice. Eur J Cancer (1976) 0.92
Neonatal newborn hearing screening: four years' experience at Ferrara University Hospital (CHEAP project): part 1. Acta Otorhinolaryngol Ital (2007) 0.92
Lupus nephritis in children. Lupus (2005) 0.91
High frequency hearing loss in the elderly: effect of age and noise exposure in an Italian group. J Laryngol Otol (2011) 0.91
A case of gentamicin accentuated hearing loss. J Laryngol Otol (1968) 0.91
Transient autonomic nervous system dysfunction during hyperacute stroke. Acta Neurol Scand (2000) 0.91